FEGTX Performance — First Eagle Global Fund
Data updated: 2026-09-28
FEGTX returned −24.47% year to date and −32.67% over one year to Jul 2026. Over one year the fund trailed its Global Mid-Cap Blend category average: $100 grew to $67, against $118 for the category. Volatility over the past 12 months was 13.25% a year. In the 12 months to Jul 2026 the fund took in a net $4.7B, and assets reached $75.98B. Returns are those of sibling share class SGENX; this class's own returns are not reported in filings.
FEGTX Growth of $100
What $100 invested in First Eagle Global Fund grew to, compounded from monthly returns reported on SEC Form N-PORT, against the Global Mid-Cap Blend category average over the same months.
| Period | FEGTX | Category average |
|---|---|---|
| 1 year (Aug 2025 – Jul 2026) | $67 | $118 |
| 3 years (Aug 2023 – Jul 2026) | $25 | $142 |
| 5 years (Aug 2021 – Jul 2026) | $8 | $150 |
| Since data start (Aug 2019 – Jul 2026) | $3 | $196 |
FEGTX Trailing Returns
Total returns to Jul 2026, from SEC N-PORT.
| Period | Total return |
|---|---|
| YTD | −24.47% |
| 1 year | −32.67% |
3- and 5-year figures withheld: returns differ from sibling classes.
FEGTX Annual Returns
Calendar-year total returns of First Eagle Global Fund, compounded from monthly SEC N-PORT returns. Partial years show the months covered.
| Year | Total return |
|---|---|
| 2026 (Jan–Jul) | −24.47% |
| 2025 | −28.90% |
| 2024 | −39.59% |
| 2023 | −39.05% |
| 2022 | −49.47% |
| 2021 | −39.33% |
| 2020 | −41.51% |
| 2019 (Aug–Dec) | −18.25% |
FEGTX Monthly Returns
Monthly total returns as reported on SEC Form N-PORT.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | +0.8% | −0.5% | −13.0% | −1.1% | −3.3% | −7.8% | −1.8% | — | — | — | — | — |
| 2025 | −0.6% | −3.8% | −4.1% | −4.4% | −2.1% | −1.8% | −5.4% | −0.8% | −0.5% | −4.5% | −2.5% | −3.0% |
| 2024 | −4.8% | −3.5% | −0.7% | −6.8% | −1.8% | −5.3% | −1.1% | −2.1% | −2.7% | −6.9% | −4.5% | −8.9% |
| 2023 | +1.6% | −8.4% | −2.4% | −3.2% | −8.1% | −0.6% | −2.8% | −7.3% | −8.5% | −6.4% | +0.3% | −1.9% |
| 2022 | −5.4% | −5.7% | −3.6% | −10.1% | −3.6% | −11.5% | −1.6% | −8.7% | −12.2% | +0.9% | +2.7% | −6.3% |
| 2021 | −6.6% | −3.0% | −1.5% | −1.4% | −1.2% | −6.7% | −4.4% | −4.6% | −7.8% | −1.9% | −8.4% | −1.0% |
| 2020 | −7.6% | −11.0% | −16.1% | +4.3% | −2.3% | −3.5% | −0.6% | −1.7% | −7.3% | −6.9% | +3.4% | −1.2% |
| 2019 | — | — | — | — | — | — | — | −5.8% | −3.2% | −3.9% | −4.5% | −2.3% |
FEGTX Risk
Risk measures from monthly returns over Aug 2025 – Jul 2026.
- 1-year volatility (annualised): 13.25%
- Best month: +0.76% (Jan 2026)
- Worst month: −12.98% (Mar 2026)
FEGTX Fund Flows
Monthly money in and out of First Eagle Global Fund, from SEC Form N-PORT.
- 12-month net flow: $4.7B
- 12-month gross sales (incl. reinvestments): $15.7B
- Sales ÷ redemptions: 1.43×
| Month | Sales | Redemptions | Net flow |
|---|---|---|---|
| Jul 2026 | $602.2M | $794.6M | −$192.3M |
| Jun 2026 | $649.6M | $781.8M | −$132.2M |
| May 2026 | $705.1M | $855.2M | −$150.1M |
| Apr 2026 | $744.8M | $911.2M | −$166.3M |
| Mar 2026 | $851.2M | $961.9M | −$110.7M |
| Feb 2026 | $1.1B | $954.4M | $138.0M |
| Jan 2026 | $1.1B | $996.6M | $142.5M |
| Dec 2025 | $6.9B | $1.8B | $5.1B |
| Nov 2025 | $734.9M | $702.3M | $32.6M |
| Oct 2025 | $875.4M | $949.9M | −$74.5M |
| Sep 2025 | $701.9M | $676.6M | $25.3M |
| Aug 2025 | $728.2M | $635.1M | $93.1M |
FEGTX Assets Under Management
Net assets of First Eagle Global Fund by report date, from SEC N-PORT filings.
| Report date | Net assets |
|---|---|
| 2026-07-31 | $75.98B |
| 2026-04-30 | $74.86B |
| 2026-01-31 | $75.08B |
| 2025-10-31 | $68.46B |
| 2025-07-31 | $62.19B |
| 2025-04-30 | $58.14B |
| 2025-01-31 | $56.15B |
| 2024-10-31 | $56.35B |
| 2024-07-31 | $54.77B |
| 2024-04-30 | $51.36B |
| 2024-01-31 | $49.94B |
| 2023-10-31 | $46.49B |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.